Fundz Deep Dive
Everything you need to win Biocomposites — in one platform.
Who to reach, what to say, and why now on Biocomposites — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Biocomposites — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Mar 03, 2025•over 1 year ago
Contract Type
partnership
EnglandManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Novo Holdings and TA Associates have entered into a partnership agreement to invest in Biocomposites, an international medical devices company specializing in products for infection management. The additional investment and resources aim to accelerate Biocomposites' international expansion and innovation in infection management products.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months